Paralkar Lab, ribosome biogenesis, ribosome hematopoiesis, leukemia, transcription, epigenetics

Grant from National Institutes of Health

Charles Antony, Post-Doctoral Researcher, is awarded a Co-Operative Center for Excellence in Hematology (CCEH) Type B grant by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) to study transcription factor dynamics and regulation in primary human bone marrow.

Grant from National Institutes of Health

The Paralkar Lab is awarded an R01 grant by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) to study the role of the chromatin binding and nucleolar protein PHF6 in the regulation of HSC self-renewal and myeloid differentiation.